Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Investor Presentation
Q2 FY25
Investor Presentation
Q2 FY22
Investor Presentation
Q1 FY22
Investor Presentation
Q1 FY21
Investor Presentation
Q2 FY20
Investor Presentation
Q2 FY20
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
7
Neutral
2
Bullish
5
Bearish
7
Neutral
2
Bullish
37
Bearish
0
Neutral
0
Bullish
32
Shivalik Rasayan Limited is primarily engaged in manufacturing organophosphate insecticides, including Dimethoate Technical and Malathion Technical.
In 2016, Shivalik Rasayan acquired a significant share in Medicamen Biotech Limited, gaining full management control in the process.
The company increased its stake in Medicamen Biotech Limited to 41.96% in 2022, signaling a strategic focus on biotech investments.
In April 2023, Shivalik Rasayan commissioned its new Agro & Specialty Chemical plant at Dahej-III, expanding its manufacturing capabilities.
Shivalik Rasayan has diversified its portfolio by venturing into pharmaceuticals, insecticides, and specialty chemicals, presenting opportunities for growth.
Fertilizers & Agrochemicals
Pesticides & Agrochemicals
607 Cr
High Risk
30.9
20.9
2.9
0.8
495.40
206.00
Bearish
7
Neutral
2
Bullish
5
Bearish
7
Neutral
2
Bullish
5
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Bearish
0
Neutral
0
Bullish
32
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
115.70 | 742 Cr | 15.16 | 2.52 | 0.00 | — | — | 0.00 | ||
19.61 | 696 Cr | 23.51 | 1.01 | 0.51 | 1.15 | 5.22 | 1.76 | ||
173.35 | 691 Cr | -8.99 | 0.91 | 0.00 | -10.03 | -1.57 | -3.90 | ||
202.25 | 506 Cr | 14.19 | 1.31 | 0.00 | 8.23 | 13.07 | 8.21 | ||
320.40 | 506 Cr | 25.74 | 0.84 | 0.16 | 2.03 | 4.36 | 2.40 | ||
71.68 | 455 Cr | 11.80 | 0.99 | 0.00 | 8.71 | 10.76 | 4.68 | ||
183.00 | 428 Cr | 25.93 | 3.51 | 0.00 | 13.55 | 15.05 | 5.32 | ||
| Median: 7 Co. | — | 173.35 | 506 Cr | 15.16 | 1.01 | 0.00 | 5.13 | 7.99 | 2.40 |
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Shivalik Rasayan Ltd (SHIVALIK) is currently trading at 385.10 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Shivalik Rasayan Limited is primarily engaged in manufacturing organophosphate insecticides, including Dimethoate Technical and Malathion Technical. In 2016, Shivalik Rasayan acquired a significant share in Medicamen Biotech Limited, gaining full management control in the process. The company increased its stake in Medicamen Biotech Limited to 41.96% in 2022, signaling a strategic focus on biotech investments. In April 2023, Shivalik Rasayan commissioned its new Agro & Specialty Chemical plant at Dahej-III, expanding its manufacturing capabilities. Shivalik Rasayan has diversified its portfolio by venturing into pharmaceuticals, insecticides, and specialty chemicals, presenting opportunities for growth.
Over the past 52 weeks, Shivalik Rasayan Ltd has traded between a low of ₹206.00 and a high of ₹495.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Shivalik Rasayan Ltd has a market capitalization of approximately 505.51. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Shivalik Rasayan Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 25.74 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 505.51 Cr, Shivalik Rasayan Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Shivalik Rasayan Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Shivalik Rasayan Ltd is 25.74. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Two special resolutions approving a preferential issue of up to 3,72,000 equity shares (public category) and up to 9,48,000 fully convertible warrants (promoter and public categories).
The board approved raising up to ₹33 crore via a preferential issue of up to 3,72,000 equity shares and 9,48,000 fully convertible warrants at ₹250 each.
